Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 22, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, May 21, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Hartaj Singh Maintained (ATXS) at Buy with Decreased Target to $25 on, May 21st, 2024
Hartaj Singh of Oppenheimer, Maintained "Astria Therapeutics, Inc." (ATXS) at Buy with Decreased Target from $29 to $25 on, May 21st, 2024.
Hartaj has made no other calls on ATXS in the last 4 months.
There are 3 other peers that have a rating on ATXS. Out of the 3 peers that are also analyzing ATXS, 0 agree with Hartaj's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Hartaj
- Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $16 on, Friday, May 10th, 2024
- Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $22 on, Friday, May 10th, 2024
- Eun Yang of "Jefferies" Maintained at Strong Buy with Increased Target to $27 on, Monday, March 25th, 2024
